Skip to main content

Advertisement

  • Correction
  • Open Access

Correction to: Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors

  • 1,
  • 1Email author,
  • 2, 3,
  • 1, 2,
  • 1 and
  • 4
BMC Geriatrics201818:128

https://doi.org/10.1186/s12877-018-0819-y

  • Received: 17 May 2018
  • Accepted: 17 May 2018
  • Published:

The original article was published in BMC Geriatrics 2017 17:244

Correction

Following the publication of this article [1], the authors noticed that the results presented in the results section of the article were erroneously reported in the results section of the abstract. This correction shows both the incorrect and correct values for the results section in the abstract.

The incorrect version is:

The total prevalence of antipsychotic use among older adults with dementia was 26% in HC, 54% in ALC, 41% in CCC, and 48% in LTC. This prevalence ranged from 38% (HC) to 73% (ALC) for those with both behavioral and psychotic symptoms and from 15% (HC) to 31% (ALC) among those with no symptoms. The regression models identified a number of variables were related to antipsychotic use in the absence of behavior or psychotic symptoms, such as bipolar disorder (OR = 6.63 in CCC; OR = 5.52 in LTC), anxious complaints (OR = 1.54 in LTC to 2.01 in CCC), and wandering (OR = 1.83 in ALC).

The corrected version is:

The total prevalence of antipsychotic use among older adults with dementia was 19% in HC, 42% in ALC, 35% in CCC, and 37% in LTC. This prevalence ranged from 39% (HC) to 70% (ALC) for those with both behavioral and psychotic symptoms and from 12% (HC) to 32% (ALC) among those with no symptoms. The regression models identified a number of variables were related to antipsychotic use in the absence of behavior or psychotic symptoms, such as bipolar disorder (OR = 5.63 in CCC; OR = 5.52 in LTC), anxious complaints (OR = 1.54 in LTC to 2.01 in CCC), and wandering (OR = 1.83 in ALC).

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
School of Public Health and Health Systems, University of Waterloo, 200 University Ave W, Waterloo, ON, N2L 3G1, Canada
(2)
Schlegel Research Institute for Aging, Waterloo, ON, Canada
(3)
Department of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, ON, Canada
(4)
Winnipeg Regional Health Authority (WRHA) Home Care Program, Winnipeg, MB, Canada

Advertisement